Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

The Fall 2022 edition of the CBS Newsletter has been released. You can access it here.

The 38th CBS annual meeting with be held at Dalhousie University in Halifax, Nova Scotia. Call for abstracts opens December 1st, 2022, and the Early Bird registration deadline is March 1st, 2023...

The Canadian Biomaterials Society is pleased to present The 2022-2023 CBS mentorship and Professional Development Program Join The 2nd Lab and the CBS-QC Student Chapter this Friday, October 7th, 2022 at 5 00 PM for a hybrid information session about this program...

Dear CBS Members, The World Biomaterials Congress 2024 WBC2024 is soliciting recommendations for plenary speakers...

Vascular tissue engineering seeks to produce biologically and mechanically responsive vascular substitutes using cells, scaffolds and bioreactors, to address the shortcomings of current vascular interventions such as coronary artery bypass grafts and to create pre-clinical testing platforms to study vascular pathologies...

Following cataract surgery, 20- 40 of patients experience reduced or afflicted vision via the development of posterior capsule opacification PCO , or secondary cataracts 1 ...

Lipid nanoparticles LNPs containing short infering RNA siRNA and messenger RNA mRNA have been clinically shown to be able to treat the root cause of genetic diseases and confer protection against infection as with Onpattro and the recent COVID-19 vaccines, respectively...

Vascular tissue engineering seeks to produce biologically and mechanically responsive vascular substitutes using cells, scaffolds and bioreactors, to address the shortcomings of current vascular interventions such as coronary artery bypass grafts and to create pre-clinical testing platforms to study vascular pathologies...

Atherosclerotic vascular disease, including peripheral arterial disease PAD , is the leading cause of mortality in North America, with PAD accounting for 1 5 of all vascular disease 1 ...